Articles for the ‘’ Category
The Commission’s upcoming Guidelines for Abuse of a Dominant Position under Article 102 TFEU has raised a lot of attention
Published 30 August 2023 by Elisabeth Eklund
Advokatfirman Delphi, Sweden
A New Approach for Assessing Alleged Abuse of a Dominant Position under Article 102 TFEU? Many pharmaceutical companies risk facing acquisitions regarding abuse of a dominant
... Read more